ArriVent BioPharma, Inc. (AVBP) Earnings
NASDAQ·Healthcare·Biotechnology
$27.65
-1.13%
Mkt Cap $1.29B
EPS — Estimate vs Actual
Mkt Cap
$1.29B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.53
NASDAQ·Healthcare·Biotechnology
$27.65
-1.13%
Mkt Cap $1.29B
Mkt Cap
$1.29B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.53